๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease

โœ Scribed by Stephen A. Harrison, Dr Adrian M. Di Bisceglie

Book ID
119928007
Publisher
Springer International Publishing AG
Year
2003
Tongue
English
Weight
268 KB
Volume
63
Category
Article
ISSN
0012-6667

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Advances in pediatric nonalcoholic fatty
Advances in pediatric nonalcoholic fatty liver disease
โœ Rohit Loomba; Claude B. Sirlin; Jeffrey B. Schwimmer; Joel E. Lavine ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 528 KB

Nonalcoholic fatty liver disease (NAFLD) has emerged as the leading cause of chronic liver disease in children and adolescents in the United States. A two-to three-fold rise in the rates of obesity and overweight in children over the last two decades is probably responsible for the NAFLD epidemic. E

Progress in understanding the pathogenes
Progress in understanding the pathogenesis of nonalcoholic fatty liver disease
โœ Richard H. Moseley ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 159 KB ๐Ÿ‘ 2 views

The pathogenesis of nonalcoholic steatohepatitis (NASH) is poorly defined. Feeding mice a diet deficient in methionine and choline (MCD diet) induces experimental NASH. Osteopontin (OPN) is a Th1 cytokine that plays an important role in several fibroinflammatory diseases. We examined the role of OPN